{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:06:13Z","timestamp":1792692373713,"version":"4.5.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-025-05302-2","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T06:12:08Z","timestamp":1763964728000},"page":"3038-3053","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hereditary syndromes and RCC: what radiologists need to know"],"prefix":"10.1007","volume":"51","author":[{"given":"Charlotte","family":"Charbel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J.","family":"Withey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Serrao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Arita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Whitworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satheesh","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Graumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungmin","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"5302_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1053\/j.sult.2016.10.002","volume":"38","author":"S Gaur","year":"2017","unstructured":"Gaur S, Turkbey B, Choyke P (2017) Hereditary Renal Tumor Syndromes: Update on Diagnosis and Management. Seminars in Ultrasound, CT and MRI 38:59\u201371. https:\/\/doi.org\/10.1053\/j.sult.2016.10.002","journal-title":"CT and MRI"},{"key":"5302_CR2","unstructured":"NCCN Clinical Practice Guidelines in Oncology - Kidney Cancer Version 3.2025"},{"key":"5302_CR3","doi-asserted-by":"publisher","unstructured":"Al-Shinnag M, Marfan H, Susman R, Wakeling J, Gustafson S, Wood S, Mallett AJ (2021) Birt-Hogg-Dub\u00e9 Syndrome and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome: An Effective Multidisciplinary Approach to Hereditary Renal Cancer Predisposing Syndromes. Front Oncol 11:. https:\/\/doi.org\/10.3389\/fonc.2021.738822","DOI":"10.3389\/fonc.2021.738822"},{"key":"5302_CR4","doi-asserted-by":"publisher","first-page":"117886","DOI":"10.1016\/j.socscimed.2025.117886","volume":"371","author":"H List","year":"2025","unstructured":"List H, Kristensen DB, Graumann O (2025) \u201cThe highest decision-making level\u201d \u2013 Multidisciplinary team meetings as boundary spaces. Social Science & Medicine 371:117886. https:\/\/doi.org\/10.1016\/j.socscimed.2025.117886","journal-title":"Social Science & Medicine"},{"key":"5302_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5694\/mja15.01157","volume":"204","author":"A Mallett","year":"2016","unstructured":"Mallett A, Fowles LF, McGaughran J, Healy H, Patel C (2016) A multidisciplinary renal genetics clinic improves patient diagnosis. Med J Aust 204:58\u201359. https:\/\/doi.org\/10.5694\/mja15.01157","journal-title":"Med J Aust"},{"key":"5302_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.acra.2020.12.019","volume":"29","author":"S Gupta","year":"2022","unstructured":"Gupta S, Kang HC, Faria SC, Choyke PL, Kundra V (2022) Tuberous Sclerosis Complex (TSC): Renal and Extrarenal Imaging. Academic Radiology 29:439\u2013449. https:\/\/doi.org\/10.1016\/j.acra.2020.12.019","journal-title":"Academic Radiology"},{"key":"5302_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1590\/0100-3984.2021.0121-en","volume":"55","author":"DA Fernandes","year":"2022","unstructured":"Fernandes DA, Mour\u00e3o JLV, Duarte J\u00c1, Dalaqua M, Reis F, Caserta NMG (2022) Imaging manifestations of von Hippel-Lindau disease: an illustrated guide focusing on abdominal manifestations. Radiol Bras 55:317\u2013323. https:\/\/doi.org\/10.1590\/0100-3984.2021.0121-en","journal-title":"Radiol Bras"},{"key":"5302_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejrad.2018.01.026","volume":"101","author":"M Czarniecki","year":"2018","unstructured":"Czarniecki M, Gautam R, Choyke PL, Turkbey B (2018) Imaging findings of hereditary renal tumors, a review of what the radiologist should know. European Journal of Radiology 101:8\u201316. https:\/\/doi.org\/10.1016\/j.ejrad.2018.01.026","journal-title":"European Journal of Radiology"},{"key":"5302_CR9","unstructured":"Renal Cell Carcinoma - Uroweb. https:\/\/uroweb.org\/guidelines\/renal-cell-carcinoma\/chapter\/hereditary-and-syndrome-specific-rcc. Accessed 11 Sept 2025"},{"key":"5302_CR10","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/s0022-5347(05)68930-6","volume":"161","author":"MM Walther","year":"1999","unstructured":"Walther MM, Choyke PL, Glenn G, Lyne JC, Rayford W, Venzon D, Linehan WM (1999) Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. J Urol 161:1475\u20131479. https:\/\/doi.org\/10.1016\/s0022-5347(05)68930-6","journal-title":"J Urol"},{"key":"5302_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.euros.2025.10.009","volume":"82","author":"C Re","year":"2025","unstructured":"Re C, Pecoraro A, Stewart GD, Cali\u00f2 A, Erdem S, Kalayci T, Uyguner ZO, Larcher A, Campi R, Amparore D, Whitworth J, Marandino L (2025) Genetic Testing and Counselling for Hereditary Renal Carcinoma: What Do Clinicians Need to Know? European Urology Open Science 82:131\u2013141. https:\/\/doi.org\/10.1016\/j.euros.2025.10.009","journal-title":"European Urology Open Science"},{"key":"5302_CR12","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.eururo.2010.08.031","volume":"58","author":"J Verine","year":"2010","unstructured":"Verine J, Pluvinage A, Bousquet G, Lehmann-Che J, de Bazelaire C, Soufir N, Mongiat-Artus P (2010) Hereditary renal cancer syndromes: an update of a systematic review. Eur Urol 58:701\u2013710. https:\/\/doi.org\/10.1016\/j.eururo.2010.08.031","journal-title":"Eur Urol"},{"key":"5302_CR13","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1007\/s00261-024-04534-y","volume":"50","author":"AH Yoon","year":"2025","unstructured":"Yoon AH, Tse JR (2025) Hereditary renal mass syndromes: a pictorial review. Abdom Radiol 50:794\u2013806. https:\/\/doi.org\/10.1007\/s00261-024-04534-y","journal-title":"Abdom Radiol"},{"key":"5302_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/jmg.2007.054304","volume":"45","author":"JR Toro","year":"2008","unstructured":"Toro JR, Wei M-H, Glenn GM, Weinreich M, Toure O, Vocke C, Turner M, Choyke P, Merino MJ, Pinto PA, Steinberg SM, Schmidt LS, Linehan WM (2008) BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dub\u00e9 syndrome: a new series of 50 families and a review of published reports. J Med Genet 45:321\u2013331. https:\/\/doi.org\/10.1136\/jmg.2007.054304","journal-title":"J Med Genet"},{"key":"5302_CR15","volume-title":"GeneReviews\u00ae","author":"R Pilarski","year":"2016","unstructured":"Pilarski R, Byrne L, Carlo MI, Hanson H, Cebulla C, Abdel-Rahman M (2016) BAP1 Tumor Predisposition Syndrome. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A (eds) GeneReviews\u00ae. University of Washington, Seattle, Seattle (WA)"},{"key":"5302_CR16","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/s0033-8389(03)00068-x","volume":"41","author":"PL Choyke","year":"2003","unstructured":"Choyke PL (2003) Imaging of hereditary renal cancer. Radiol Clin North Am 41:1037\u20131051. https:\/\/doi.org\/10.1016\/s0033-8389(03)00068-x","journal-title":"Radiol Clin North Am"},{"key":"5302_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13023-018-0870-y","volume":"13","author":"D Ebrahimi-Fakhari","year":"2018","unstructured":"Ebrahimi-Fakhari D, Mann LL, Poryo M, Graf N, von Kries R, Heinrich B, Ebrahimi-Fakhari D, Flotats-Bastardas M, Gortner L, Zemlin M, Meyer S (2018) Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study. Orphanet J Rare Dis 13:117. https:\/\/doi.org\/10.1186\/s13023-018-0870-y","journal-title":"Orphanet J Rare Dis"},{"key":"5302_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1053\/j.ackd.2013.10.001","volume":"21","author":"NB Haas","year":"2014","unstructured":"Haas NB, Nathanson KL (2014) Hereditary Kidney Cancer Syndromes. Advances in Chronic Kidney Disease 21:81\u201390. https:\/\/doi.org\/10.1053\/j.ackd.2013.10.001","journal-title":"Advances in Chronic Kidney Disease"},{"key":"5302_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12098-011-0453-6","volume":"79","author":"P Gupta","year":"2012","unstructured":"Gupta P, Mukund A, S H C, Gupta AK (2012) Tuberous sclerosis complex: imaging findings. Indian J Pediatr 79:127\u2013129. https:\/\/doi.org\/10.1007\/s12098-011-0453-6","journal-title":"Indian J Pediatr"},{"key":"5302_CR20","doi-asserted-by":"publisher","first-page":"W79-86","DOI":"10.2214\/AJR.14.13245","volume":"205","author":"KS Jhaveri","year":"2015","unstructured":"Jhaveri KS, Elmi A, Hosseini-Nik H, Hedgire S, Evans A, Jewett M, Harisinghani M (2015) Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma. AJR Am J Roentgenol 205:W79-86. https:\/\/doi.org\/10.2214\/AJR.14.13245","journal-title":"AJR Am J Roentgenol"},{"key":"5302_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1148\/radiol.2391050102","volume":"239","author":"JK Kim","year":"2006","unstructured":"Kim JK, Kim SH, Jang YJ, Ahn H, Kim C-S, Park H, Lee JW, Kim S, Cho K-S (2006) Renal angiomyolipoma with minimal fat: differentiation from other neoplasms at double-echo chemical shift FLASH MR imaging. Radiology 239:174\u2013180. https:\/\/doi.org\/10.1148\/radiol.2391050102","journal-title":"Radiology"},{"key":"5302_CR22","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1148\/radiol.12112087","volume":"265","author":"N Hindman","year":"2012","unstructured":"Hindman N, Ngo L, Genega EM, Melamed J, Wei J, Braza JM, Rofsky NM, Pedrosa I (2012) Angiomyolipoma with Minimal Fat: Can It Be Differentiated from Clear Cell Renal Cell Carcinoma by Using Standard MR Techniques? Radiology 265:468\u2013477. https:\/\/doi.org\/10.1148\/radiol.12112087","journal-title":"Radiology"},{"key":"5302_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1148\/radiol.12111205","volume":"263","author":"K Sasiwimonphan","year":"2012","unstructured":"Sasiwimonphan K, Takahashi N, Leibovich BC, Carter RE, Atwell TD, Kawashima A (2012) Small (<\u20094\u00a0cm) Renal Mass: Differentiation of Angiomyolipoma without Visible Fat from Renal Cell Carcinoma Utilizing MR Imaging. Radiology 263:160\u2013168. https:\/\/doi.org\/10.1148\/radiol.12111205","journal-title":"Radiology"},{"key":"5302_CR24","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1177\/0284185117723371","volume":"59","author":"S Woo","year":"2018","unstructured":"Woo S, Kim SY, Cho JY, Kim SH (2018) Differentiation between papillary renal cell carcinoma and fat-poor angiomyolipoma: a preliminary study assessing detection of intratumoral hemorrhage with chemical shift MRI and T2*-weighted gradient echo. Acta Radiol 59:627\u2013634. https:\/\/doi.org\/10.1177\/0284185117723371","journal-title":"Acta Radiol"},{"key":"5302_CR25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/ejhg.2016.173","volume":"25","author":"MLM Binderup","year":"2017","unstructured":"Binderup MLM, Galanakis M, Budtz-J\u00f8rgensen E, Kosteljanetz M, Luise Bisgaard M (2017) Prevalence, birth incidence, and penetrance of von Hippel\u2013Lindau disease (vHL) in Denmark. Eur J Hum Genet 25:301\u2013307. https:\/\/doi.org\/10.1038\/ejhg.2016.173","journal-title":"Eur J Hum Genet"},{"key":"5302_CR26","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1111\/cas.15728","volume":"114","author":"H Takamori","year":"2023","unstructured":"Takamori H, Yamasaki T, Kitadai R, Minamishima YA, Nakamura E (2023) Development of drugs targeting hypoxia-inducible factor against tumor cells with VHL mutation: Story of 127 years. Cancer Sci 114:1208\u20131217. https:\/\/doi.org\/10.1111\/cas.15728","journal-title":"Cancer Sci"},{"key":"5302_CR27","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ajmg.a.33139","volume":"152A","author":"DG Evans","year":"2010","unstructured":"Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, Lalloo F (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A 152A:327\u2013332. https:\/\/doi.org\/10.1002\/ajmg.a.33139","journal-title":"Am J Med Genet A"},{"key":"5302_CR28","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1136\/jmedgenet-2018-105567","volume":"56","author":"X Peng","year":"2019","unstructured":"Peng X, Chen J, Wang J, Peng S, Liu S, Ma K, Zhou J, Hong B, Zhou B, Zhang J, Cai L, Gong K (2019) Natural history of renal tumours in von Hippel-Lindau disease: a large retrospective study of Chinese patients. J Med Genet 56:380\u2013387. https:\/\/doi.org\/10.1136\/jmedgenet-2018-105567","journal-title":"J Med Genet"},{"key":"5302_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/humu.10302","volume":"23","author":"JK Maranchie","year":"2004","unstructured":"Maranchie JK, Afonso A, Albert PS, Kalyandrug S, Phillips JL, Zhou S, Peterson J, Ghadimi BM, Hurley K, Riss J, Vasselli JR, Ried T, Zbar B, Choyke P, Walther MM, Klausner RD, Linehan WM (2004) Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location. Hum Mutat 23:40\u201346. https:\/\/doi.org\/10.1002\/humu.10302","journal-title":"Hum Mutat"},{"key":"5302_CR30","first-page":"2089","volume":"149","author":"IA Lubensky","year":"1996","unstructured":"Lubensky IA, Gnarra JR, Bertheau P, Walther MM, Linehan WM, Zhuang Z (1996) Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients. Am J Pathol 149:2089\u20132094","journal-title":"Am J Pathol"},{"key":"5302_CR31","volume-title":"GeneReviews\u00ae","author":"RS van Leeuwaarde","year":"1993","unstructured":"van Leeuwaarde RS, Ahmad S, van Nesselrooij B, Zandee W, Giles RH (1993) Von Hippel-Lindau Syndrome. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A (eds) GeneReviews\u00ae. University of Washington, Seattle, Seattle (WA)"},{"key":"5302_CR32","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1046\/j.1365-2559.2000.00857.x","volume":"36","author":"F Paraf","year":"2000","unstructured":"Paraf F, Chauveau D, Chr\u00e9tien Y, Richard S, Gr\u00fcnfeld JP, Droz D (2000) Renal lesions in von Hippel-Lindau disease: immunohistochemical expression of nephron differentiation molecules, adhesion molecules and apoptosis proteins. Histopathology 36:457\u2013465. https:\/\/doi.org\/10.1046\/j.1365-2559.2000.00857.x","journal-title":"Histopathology"},{"key":"5302_CR33","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.2214\/ajr.159.6.1442389","volume":"159","author":"PL Choyke","year":"1992","unstructured":"Choyke PL, Glenn GM, Walther MM, Zbar B, Weiss GH, Alexander RB, Hayes WS, Long JP, Thakore KN, Linehan WM (1992) The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients. AJR Am J Roentgenol 159:1229\u20131234. https:\/\/doi.org\/10.2214\/ajr.159.6.1442389","journal-title":"AJR Am J Roentgenol"},{"key":"5302_CR34","doi-asserted-by":"publisher","first-page":"JCO2018792549","DOI":"10.1200\/JCO.2018.79.2549","volume":"36","author":"JJ Hsieh","year":"2018","unstructured":"Hsieh JJ, Le VH, Oyama T, Ricketts CJ, Ho TH, Cheng EH (2018) Chromosome 3p Loss-Orchestrated VHL, HIF, and Epigenetic Deregulation in Clear Cell Renal Cell Carcinoma. J Clin Oncol 36:JCO2018792549. https:\/\/doi.org\/10.1200\/JCO.2018.79.2549","journal-title":"J Clin Oncol"},{"key":"5302_CR35","doi-asserted-by":"publisher","first-page":"e162480","DOI":"10.1172\/JCI162480","volume":"132","author":"WG Kaelin","year":"2022","unstructured":"Kaelin WG (2022) Von Hippel-Lindau disease: insights into oxygen sensing, protein degradation, and cancer. J Clin Invest 132:e162480. https:\/\/doi.org\/10.1172\/JCI162480","journal-title":"J Clin Invest"},{"key":"5302_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.clinimag.2020.06.010","volume":"68","author":"AK Paschall","year":"2020","unstructured":"Paschall AK, Nikpanah M, Farhadi F, Jones EC, Wakim PG, Dwyer AJ, Gautam R, Merino MJ, Srinivasan R, Linehan WM, Malayeri AA (2020) Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome: Spectrum of imaging findings. Clinical Imaging 68:14\u201319. https:\/\/doi.org\/10.1016\/j.clinimag.2020.06.010","journal-title":"Clinical Imaging"},{"key":"5302_CR37","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/cncr.33997","volume":"128","author":"E Lu","year":"2022","unstructured":"Lu E, Hatchell KE, Nielsen SM, Esplin ED, Ouyang K, Nykamp K, Zavoshi S, Li S, Zhang L, Wilde BR, Christofk HR, Boutros PC, Shuch B (2022) Fumarate hydratase variant prevalence and manifestations among individuals receiving germline testing. Cancer 128:675\u2013684. https:\/\/doi.org\/10.1002\/cncr.33997","journal-title":"Cancer"},{"key":"5302_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40644-021-00392-9","volume":"21","author":"I Nikolovski","year":"2021","unstructured":"Nikolovski I, Carlo MI, Chen Y-B, Vargas HA (2021) Imaging features of fumarate hydratase-deficient renal cell carcinomas: a retrospective study. Cancer Imaging 21:24. https:\/\/doi.org\/10.1186\/s40644-021-00392-9","journal-title":"Cancer Imaging"},{"key":"5302_CR39","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.euo.2019.11.002","volume":"3","author":"C Forde","year":"2020","unstructured":"Forde C, Lim DHK, Alwan Y, Burghel G, Butland L, Cleaver R, Dixit A, Evans DG, Hanson H, Lalloo F, Oliveira P, Vialard L, Wallis Y, Maher ER, Woodward ER (2020) Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals. Eur Urol Oncol 3:764\u2013772. https:\/\/doi.org\/10.1016\/j.euo.2019.11.002","journal-title":"Eur Urol Oncol"},{"key":"5302_CR40","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1016\/j.juro.2007.01.155","volume":"177","author":"RL Grubb","year":"2007","unstructured":"Grubb RL, Franks ME, Toro J, Middelton L, Choyke L, Fowler S, Torres-Cabala C, Glenn GM, Choyke P, Merino MJ, Zbar B, Pinto PA, Srinivasan R, Coleman JA, Linehan WM (2007) Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol 177:2074\u20132079; discussion 2079\u20132080. https:\/\/doi.org\/10.1016\/j.juro.2007.01.155","journal-title":"J Urol"},{"key":"5302_CR41","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","volume":"82","author":"H Moch","year":"2022","unstructured":"Moch H, Amin MB, Berney DM, Comp\u00e9rat EM, Gill AJ, Hartmann A, Menon S, Raspollini MR, Rubin MA, Srigley JR, Hoon Tan P, Tickoo SK, Tsuzuki T, Turajlic S, Cree I, Netto GJ (2022) The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs\u2014Part A: Renal, Penile, and Testicular Tumours. European Urology 82:458\u2013468. https:\/\/doi.org\/10.1016\/j.eururo.2022.06.016","journal-title":"European Urology"},{"key":"5302_CR42","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","volume":"82","author":"L Bukavina","year":"2022","unstructured":"Bukavina L, Bensalah K, Bray F, Carlo M, Challacombe B, Karam JA, Kassouf W, Mitchell T, Montironi R, O\u2019Brien T, Panebianco V, Scelo G, Shuch B, van Poppel H, Blosser CD, Psutka SP (2022) Epidemiology of Renal Cell Carcinoma: 2022 Update. European Urology 82:529\u2013542. https:\/\/doi.org\/10.1016\/j.eururo.2022.08.019","journal-title":"European Urology"},{"key":"5302_CR43","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00428-024-03768-x","volume":"484","author":"LM Nova-Camacho","year":"2024","unstructured":"Nova-Camacho LM, Acosta AM, Akgul M, Panizo A, Galea LA, Val-Carreres A, Talavera JA, Guerrero-Setas D, Martin-Arruti M, Ruiz I, Garc\u00eda-Martos M, Sangoi AR (2024) Biphasic papillary (biphasic squamoid alveolar) renal cell carcinoma: a clinicopathologic and molecular study of 17 renal cell carcinomas including 10 papillary adenomas. Virchows Arch 484:441\u2013449. https:\/\/doi.org\/10.1007\/s00428-024-03768-x","journal-title":"Virchows Arch"},{"key":"5302_CR44","doi-asserted-by":"publisher","first-page":"e221738","DOI":"10.1136\/thorax-2024-221738","volume":"80","author":"B Yngvadottir","year":"2025","unstructured":"Yngvadottir B, Richman L, Andreou A, Woodley J, Luharia A, Lim D, Maher ER, Marciniak SJ (2025) Inherited predisposition to pneumothorax: estimating the frequency of Birt-Hogg-Dub\u00e9 syndrome from genomics and population cohorts. Thorax 80:e221738. https:\/\/doi.org\/10.1136\/thorax-2024-221738","journal-title":"Thorax"},{"key":"5302_CR45","doi-asserted-by":"publisher","first-page":"2449271","DOI":"10.1080\/20018525.2024.2449271","volume":"12","author":"MM Holmager","year":"2025","unstructured":"Holmager MM, Wordenskjold Stougaard S, Graumann O, Pr\u00e6stegaard M, Ousager LB, Lund L, Schuster A, Falster C, Davidsen JR (2025) Trends in pulmonary function in patients with Birt-Hogg-Dub\u00e9 syndrome: a retrospective cohort study. Eur Clin Respir J 12:2449271. https:\/\/doi.org\/10.1080\/20018525.2024.2449271","journal-title":"Eur Clin Respir J"},{"key":"5302_CR46","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.2214\/AJR.17.18071","volume":"209","author":"S Gupta","year":"2017","unstructured":"Gupta S, Kang HC, Ganeshan D, Morani A, Gautam R, Choyke PL, Kundra V (2017) The ABCs of BHD: An In-Depth Review of Birt-Hogg-Dub\u00e9 Syndrome. AJR Am J Roentgenol 209:1291\u20131296. https:\/\/doi.org\/10.2214\/AJR.17.18071","journal-title":"AJR Am J Roentgenol"},{"key":"5302_CR47","doi-asserted-by":"publisher","first-page":"e0269358","DOI":"10.1371\/journal.pone.0269358","volume":"17","author":"HJ Park","year":"2022","unstructured":"Park HJ, Kim Y-J, Kim M-J, Kim HC (2022) Epidemiology and clinical features of Birt-Hogg-Dub\u00e9 syndrome: A nationwide population-based study in South Korea. PLoS One 17:e0269358. https:\/\/doi.org\/10.1371\/journal.pone.0269358","journal-title":"PLoS One"},{"key":"5302_CR48","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13023-014-0163-z","volume":"9","author":"PR Benusiglio","year":"2014","unstructured":"Benusiglio PR, Giraud S, Deveaux S, M\u00e9jean A, Correas J-M, Joly D, Timsit M-O, Ferlicot S, Verkarre V, Abadie C, Chauveau D, Leroux D, Avril M-F, Cordier J-F, Richard S, French National Cancer Institute Inherited Predisposition to Kidney Cancer Network (2014) Renal cell tumour characteristics in patients with the Birt-Hogg-Dub\u00e9 cancer susceptibility syndrome: a retrospective, multicentre study. Orphanet J Rare Dis 9:163. https:\/\/doi.org\/10.1186\/s13023-014-0163-z","journal-title":"Orphanet J Rare Dis"},{"key":"5302_CR49","volume-title":"GeneReviews\u00ae","author":"EC Sattler","year":"1993","unstructured":"Sattler EC, Steinlein OK (1993) Birt-Hogg-Dub\u00e9 Syndrome. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A (eds) GeneReviews\u00ae. University of Washington, Seattle, Seattle (WA)"},{"key":"5302_CR50","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/gim.2014.147","volume":"17","author":"H Hampel","year":"2015","unstructured":"Hampel H, Bennett RL, Buchanan A, Pearlman R, Wiesner GL (2015) A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. Genetics in Medicine 17:70\u201387. https:\/\/doi.org\/10.1038\/gim.2014.147","journal-title":"Genetics in Medicine"},{"key":"5302_CR51","unstructured":"Akobeng MA, Bhayana R, Di Loreto M, Taffel M, Woo S, Tirumani S, Shanbhogue K, Prendeville S, Elsayes K, Schieda N, Silverman S, Krishna S (Status: in press) Renal Oncocytic Neoplasms: A Review of Pathology Classification Updates, Imaging Presentations, and Management. RadioGraphics"},{"key":"5302_CR52","doi-asserted-by":"publisher","first-page":"e230063","DOI":"10.1148\/rycan.230063","volume":"6","author":"C Charbel","year":"2024","unstructured":"Charbel C, Causa Andrieu PI, Soliman M, Woo S, Zheng J, Capanu M, Nikolovski I, Vargas HA, Abusamra M, Carlo MI (2024) The Prevalence and Radiologic Features of Renal Cancers Associated with FLCN, BAP1, SDH, and MET Germline Mutations. Radiology: Imaging Cancer 6:e230063. https:\/\/doi.org\/10.1148\/rycan.230063","journal-title":"Radiology: Imaging Cancer"},{"key":"5302_CR53","doi-asserted-by":"publisher","first-page":"598","DOI":"10.2214\/AJR.12.10372","volume":"201","author":"S Woo","year":"2013","unstructured":"Woo S, Cho JY, Kim SH, Kim SY (2013) Comparison of segmental enhancement inversion on biphasic MDCT between small renal oncocytomas and chromophobe renal cell carcinomas. AJR Am J Roentgenol 201:598\u2013604. https:\/\/doi.org\/10.2214\/AJR.12.10372","journal-title":"AJR Am J Roentgenol"},{"key":"5302_CR54","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1148\/radiol.2442060927","volume":"244","author":"J Zhang","year":"2007","unstructured":"Zhang J, Lefkowitz RA, Ishill NM, Wang L, Moskowitz CS, Russo P, Eisenberg H, Hricak H (2007) Solid renal cortical tumors: differentiation with CT. Radiology 244:494\u2013504. https:\/\/doi.org\/10.1148\/radiol.2442060927","journal-title":"Radiology"},{"key":"5302_CR55","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","volume":"70","author":"H Moch","year":"2016","unstructured":"Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM (2016) The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. Eur Urol 70:93\u2013105. https:\/\/doi.org\/10.1016\/j.eururo.2016.02.029","journal-title":"Eur Urol"},{"key":"5302_CR56","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1097\/PAS.0000000000000292","volume":"38","author":"AJ Gill","year":"2014","unstructured":"Gill AJ, Hes O, Papathomas T, \u0160edivcov\u00e1 M, Tan PH, Agaimy A, Andresen PA, Kedziora A, Clarkson A, Toon CW, Sioson L, Watson N, Chou A, Paik J, Clifton-Bligh RJ, Robinson BG, Benn DE, Hills K, Maclean F, Niemeijer ND, Vlatkovic L, Hartmann A, Corssmit EPM, van Leenders GJLH, Przybycin C, McKenney JK, Magi-Galluzzi C, Yilmaz A, Yu D, Nicoll KD, Yong JL, Sibony M, Yakirevich E, Fleming S, Chow CW, Miettinen M, Michal M, Trpkov K (2014) Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients. Am J Surg Pathol 38:1588\u20131602. https:\/\/doi.org\/10.1097\/PAS.0000000000000292","journal-title":"Am J Surg Pathol"},{"key":"5302_CR57","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s41379-021-00998-1","volume":"35","author":"TL Fuchs","year":"2022","unstructured":"Fuchs TL, Maclean F, Turchini J, Vargas AC, Bhattarai S, Agaimy A, Hartmann A, Kao C-S, Ellis C, Bonert M, Leroy X, Kunju LP, Schwartz L, Matsika A, Williamson SR, Rao P, Divatia M, Guarch R, Algaba F, Balancin ML, Zhou M, Samaratunga H, da Cunha IW, Brimo F, Ryan A, Clouston D, Aron M, O\u2019Donnell M, Chan E, Hirsch MS, Moch H, Pang C-Y, Wah C, Yin W, Perry-Keene J, Yilmaz A, Chou A, Clarkson A, van der Westhuizen G, Morrison E, Zwi J, Hes O, Trpkov K, Gill AJ (2022) Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients. Mod Pathol 35:836\u2013849. https:\/\/doi.org\/10.1038\/s41379-021-00998-1","journal-title":"Mod Pathol"},{"key":"5302_CR58","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1148\/rg.2019180151","volume":"39","author":"SJ Withey","year":"2019","unstructured":"Withey SJ, Perrio S, Christodoulou D, Izatt L, Carroll P, Velusamy A, Obholzer R, Lewington V, Jacques AET (2019) Imaging Features of Succinate Dehydrogenase-deficient Pheochromocytoma-Paraganglioma Syndromes. Radiographics 39:1393\u20131410. https:\/\/doi.org\/10.1148\/rg.2019180151","journal-title":"Radiographics"},{"key":"5302_CR59","doi-asserted-by":"publisher","unstructured":"Lee C-H, Gundem G, Lee W, Chen Y-B, Cross JR, Dong Y, Redzematovic A, Mano R, Wei EY, Cheng EH, Srinivasan R, Oschwald D, Hakimi AA, Dunphy MP, Linehan WM, Papaemmanuil E, Hsieh JJ (2017) Persistent Severe Hyperlactatemia and Metabolic Derangement in Lethal SDHB-Mutated Metastatic Kidney Cancer: Clinical Challenges and Examples of Extreme Warburg Effect. JCO Precis Oncol 1:PO.16.00007. https:\/\/doi.org\/10.1200\/PO.16.00007","DOI":"10.1200\/PO.16.00007"},{"key":"5302_CR60","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/j.juro.2012.08.030","volume":"188","author":"CJ Ricketts","year":"2012","unstructured":"Ricketts CJ, Shuch B, Vocke CD, Metwalli AR, Bratslavsky G, Middelton L, Yang Y, Wei M-H, Pautler SE, Peterson J, Stolle CA, Zbar B, Merino MJ, Schmidt LS, Pinto PA, Srinivasan R, Pacak K, Linehan WM (2012) Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. J Urol 188:2063\u20132071. https:\/\/doi.org\/10.1016\/j.juro.2012.08.030","journal-title":"J Urol"},{"key":"5302_CR61","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13000-024-01561-7","volume":"19","author":"S-S Dong","year":"2024","unstructured":"Dong S-S, Wang Z-Y, Tian X-C, Wang C-M, Xu Q, Xu C, Yang W, Gu X-W, Xiao Q (2024) Keratin 20 positive SDH-deficient renal cell carcinoma: a case report and literature review. Diagn Pathol 19:137. https:\/\/doi.org\/10.1186\/s13000-024-01561-7","journal-title":"Diagn Pathol"},{"key":"5302_CR62","doi-asserted-by":"publisher","first-page":"110280","DOI":"10.1016\/j.clinimag.2024.110280","volume":"115","author":"A Chaurasia","year":"2024","unstructured":"Chaurasia A, Turkbey EB, Firouzabadi FD, Singh S, Samimi S, Gopal N, Millo C, Ball MW, Linehan WM, Malayeri AA (2024) Imaging finding of renal masses associated with pathogenic variation in succinate dehydrogenase subunit B gene. Clin Imaging 115:110280. https:\/\/doi.org\/10.1016\/j.clinimag.2024.110280","journal-title":"Clin Imaging"},{"key":"5302_CR63","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1001\/jamadermatol.2017.2330","volume":"153","author":"AM Haugh","year":"2017","unstructured":"Haugh AM, Njauw C-N, Bubley JA, Verz\u00ec AE, Zhang B, Kudalkar E, VandenBoom T, Walton K, Swick BL, Kumar R, Rana HQ, Cochrane S, McCormick SR, Shea CR, Tsao H, Gerami P (2017) Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature. JAMA Dermatol 153:999\u20131006. https:\/\/doi.org\/10.1001\/jamadermatol.2017.2330","journal-title":"JAMA Dermatol"},{"key":"5302_CR64","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/cge.12630","volume":"89","author":"K Rai","year":"2016","unstructured":"Rai K, Pilarski R, Cebulla CM, Abdel-Rahman MH (2016) Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases. Clin Genet 89:285\u2013294. https:\/\/doi.org\/10.1111\/cge.12630","journal-title":"Clin Genet"},{"key":"5302_CR65","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/ajcp\/aqaa176","volume":"155","author":"AJ Gallan","year":"2021","unstructured":"Gallan AJ, Parilla M, Segal J, Ritterhouse L, Antic T (2021) BAP1-Mutated Clear Cell Renal Cell Carcinoma. Am J Clin Pathol 155:718\u2013728. https:\/\/doi.org\/10.1093\/ajcp\/aqaa176","journal-title":"Am J Clin Pathol"},{"key":"5302_CR66","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.ijrobp.2022.12.023","volume":"116","author":"X-H Wu","year":"2023","unstructured":"Wu X-H, Zhu J-M, Lin B-H, Qiu Q-R-S, Ruan Z-T, Wei Y, Xue X-Y, Zheng Q, Chen S-H, Xu N (2023) Semantic Computed Tomography Features for Predicting BRCA1-associated Protein 1 and\/or Tumor Protein p53 Gene Mutation Status in Clear Cell Renal Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics 116:666\u2013675. https:\/\/doi.org\/10.1016\/j.ijrobp.2022.12.023","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"5302_CR67","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1148\/radiol.13130663","volume":"270","author":"CA Karlo","year":"2014","unstructured":"Karlo CA, Di Paolo PL, Chaim J, Hakimi AA, Ostrovnaya I, Russo P, Hricak H, Motzer R, Hsieh JJ, Akin O (2014) Radiogenomics of Clear Cell Renal Cell Carcinoma: Associations between CT Imaging Features and Mutations. Radiology 270:464\u2013471. https:\/\/doi.org\/10.1148\/radiol.13130663","journal-title":"Radiology"},{"key":"5302_CR68","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1158\/1078-0432.CCR-24-2171","volume":"31","author":"O Michaeli","year":"2025","unstructured":"Michaeli O, Kim SY, Mitchell SG, Jongmans MCJ, Wasserman JD, Perrino MR, Das A, MacFarland SP, Scollon SR, Greer M-LC, Sobreira N, Gallinger B, Lupo PJ, Malkin D, Schneider KW, Schultz KAP, Foulkes WD, Woodward ER, Stewart DR (2025) Update on Cancer Screening in Children with Syndromes of Bone Lesions, Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome, and Other Rare Syndromes. Clin Cancer Res 31:457\u2013465. https:\/\/doi.org\/10.1158\/1078-0432.CCR-24-2171","journal-title":"Clin Cancer Res"},{"key":"5302_CR69","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1002\/cncr.34896","volume":"129","author":"AB Daniels","year":"2023","unstructured":"Daniels AB, Tirosh A, Huntoon K, Mehta GU, Spiess PE, Friedman DL, Waguespack SG, Kilkelly JE, Rednam S, Pruthi S, Jonasch EA, Baum L, Chahoud J, International VHL Surveillance Guidelines Consortium (2023) Guidelines for surveillance of patients with von Hippel-Lindau disease: Consensus statement of the International VHL Surveillance Guidelines Consortium and VHL Alliance. Cancer 129:2927\u20132940. https:\/\/doi.org\/10.1002\/cncr.34896","journal-title":"Cancer"},{"key":"5302_CR70","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000333348","volume":"88","author":"CA Jilg","year":"2012","unstructured":"Jilg CA, Neumann HP, Gl\u00e4sker S, Sch\u00e4fer O, Ardelt PU, Schwardt M, Schultze-Seemann W (2012) Growth kinetics in von Hippel-Lindau-associated renal cell carcinoma. Urol Int 88:71\u201378. https:\/\/doi.org\/10.1159\/000333348","journal-title":"Urol Int"},{"key":"5302_CR71","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40644-023-00535-0","volume":"23","author":"M Cheng","year":"2023","unstructured":"Cheng M, Duzgol C, Kim T-H, Ghafoor S, Becker AS, Causa Andrieu PI, Gangai N, Jiang H, Hakimi AA, Vargas HA, Woo S (2023) Sarcomatoid renal cell carcinoma: MRI features and their association with survival. Cancer Imaging 23:16. https:\/\/doi.org\/10.1186\/s40644-023-00535-0","journal-title":"Cancer Imaging"},{"key":"5302_CR72","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s10689-014-9735-2","volume":"13","author":"FH Menko","year":"2014","unstructured":"Menko FH, Maher ER, Schmidt LS, Middelton LA, Aittom\u00e4ki K, Tomlinson I, Richard S, Linehan WM (2014) Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment. Fam Cancer 13:637\u2013644. https:\/\/doi.org\/10.1007\/s10689-014-9735-2","journal-title":"Fam Cancer"},{"key":"5302_CR73","unstructured":"PDQ Cancer Genetics Editorial Board (2002) Hereditary Papillary Renal Carcinoma (PDQ\u00ae): Health Professional Version. In: PDQ Cancer Information Summaries. National Cancer Institute (US), Bethesda (MD)"},{"key":"5302_CR74","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/s41431-024-01671-2","volume":"32","author":"M Geilswijk","year":"2024","unstructured":"Geilswijk M, Genuardi M, Woodward ER, Nightingale K, Huber J, Madsen MG, Liekelema-van der Heij D, Lisseman I, Marl\u00e9-Ballang\u00e9 J, McCarthy C, Menko FH, Moorselaar RJA van, Radzikowska E, Richard S, Rajan N, Sommerlund M, Wetscherek MTA, Di Donato N, Maher ER, Brunet J (2024) ERN GENTURIS clinical practice guidelines for the diagnosis, surveillance and management of people with Birt-Hogg-Dub\u00e9 syndrome. Eur J Hum Genet 32:1542\u20131550. https:\/\/doi.org\/10.1038\/s41431-024-01671-2","journal-title":"Eur J Hum Genet"},{"key":"5302_CR75","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1177\/10668969231157317","volume":"31","author":"Y Liu","year":"2023","unstructured":"Liu Y, Li Y, Xu H, Zhou L, Yang X, Wang C (2023) Exploration of Morphological Features of Clear Cell Renal Cell Carcinoma With PBRM1, SETD2, BAP1, or KDM5C Mutations. Int J Surg Pathol 31:1485\u20131494. https:\/\/doi.org\/10.1177\/10668969231157317","journal-title":"Int J Surg Pathol"},{"key":"5302_CR76","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.3390\/cancers15133322","volume":"15","author":"FH Osman","year":"2023","unstructured":"Osman FH, Chan VW-S, Breen DJ, King A, Nielsen TK, Garnon J, Alcorn D, Lagerveld B, Graumann O, Keeley FX, Walkden M, de Kerviler \u00c9, Wah TM (2023) Oncological and Peri-Operative Outcomes of Percutaneous Cryoablation of Renal Cell Carcinoma for Patients with Hereditary RCC Diseases\u2014An Analysis of European Multi-Centre Prospective EuRECA Registry. Cancers (Basel) 15:3322. https:\/\/doi.org\/10.3390\/cancers15133322","journal-title":"Cancers (Basel)"},{"key":"5302_CR77","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s40001-025-02592-6","volume":"30","author":"Z Wang","year":"2025","unstructured":"Wang Z, Jiang Y, Huang W, Liu X, Shan Q, Wu Z, Yang Z, Ding X, Wang Z (2025) Impact of thermal ablation\/cryoablation treatment on prognosis among patients with kidney cancer: a SEER database-based cohort study. Eur J Med Res 30:391. https:\/\/doi.org\/10.1186\/s40001-025-02592-6","journal-title":"Eur J Med Res"},{"key":"5302_CR78","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s00261-022-03689-w","volume":"48","author":"A Chaurasia","year":"2023","unstructured":"Chaurasia A, Gopal N, Dehghani Firouzabadi F, Yazdian Anari P, Wakim P, Ball MW, Jones EC, Turkbey B, Huda F, Linehan WM, Turkbey EB, Malayeri AA (2023) Role of ultra-high b-value DWI in the imaging of hereditary leiomyomatosis and renal cell carcinoma (HLRCC). Abdom Radiol (NY) 48:340\u2013349. https:\/\/doi.org\/10.1007\/s00261-022-03689-w","journal-title":"Abdom Radiol (NY)"},{"key":"5302_CR79","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1007\/s00261-015-0386-z","volume":"40","author":"AB Shinagare","year":"2015","unstructured":"Shinagare AB, Vikram R, Jaffe C, Akin O, Kirby J, Huang E, Freymann J, Sainani NI, Sadow CA, Bathala TK, Rubin DL, Oto A, Heller MT, Surabhi VR, Katabathina V, Silverman SG (2015) Radiogenomics of clear cell renal cell carcinoma: preliminary findings of The Cancer Genome Atlas-Renal Cell Carcinoma (TCGA-RCC) Imaging Research Group. Abdom Imaging 40:1684\u20131692. https:\/\/doi.org\/10.1007\/s00261-015-0386-z","journal-title":"Abdom Imaging"},{"key":"5302_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/EDBK_350862","volume":"42","author":"R Rasmussen","year":"2022","unstructured":"Rasmussen R, Sanford T, Parwani AV, Pedrosa I (2022) Artificial Intelligence in Kidney Cancer. Am Soc Clin Oncol Educ Book 42:1\u201311. https:\/\/doi.org\/10.1200\/EDBK_350862","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"5302_CR81","doi-asserted-by":"publisher","first-page":"215008","DOI":"10.1088\/1361-6560\/aae5cd","volume":"63","author":"X Chen","year":"2018","unstructured":"Chen X, Zhou Z, Hannan R, Thomas K, Pedrosa I, Kapur P, Brugarolas J, Mou X, Wang J (2018) Reliable gene mutation prediction in clear cell renal cell carcinoma through multi-classifier multi-objective radiogenomics model. Phys Med Biol 63:215008. https:\/\/doi.org\/10.1088\/1361-6560\/aae5cd","journal-title":"Phys Med Biol"},{"key":"5302_CR82","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1177\/0284185119881742","volume":"61","author":"B Kocak","year":"2020","unstructured":"Kocak B, Durmaz ES, Kaya OK, Kilickesmez O (2020) Machine learning-based unenhanced CT texture analysis for predicting BAP1 mutation status of clear cell renal cell carcinomas. Acta Radiol 61:856\u2013864. https:\/\/doi.org\/10.1177\/0284185119881742","journal-title":"Acta Radiol"},{"key":"5302_CR83","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fonc.2020.00279","volume":"10","author":"Z Feng","year":"2020","unstructured":"Feng Z, Zhang L, Qi Z, Shen Q, Hu Z, Chen F (2020) Identifying BAP1 Mutations in Clear-Cell Renal Cell Carcinoma by CT Radiomics: Preliminary Findings. Front Oncol 10:279. https:\/\/doi.org\/10.3389\/fonc.2020.00279","journal-title":"Front Oncol"},{"key":"5302_CR84","doi-asserted-by":"publisher","first-page":"041009","DOI":"10.1117\/1.JMI.2.4.041009","volume":"2","author":"P Ghosh","year":"2015","unstructured":"Ghosh P, Tamboli P, Vikram R, Rao A (2015) Imaging-genomic pipeline for identifying gene mutations using three-dimensional intra-tumor heterogeneity features. J Med Imaging (Bellingham) 2:041009. https:\/\/doi.org\/10.1117\/1.JMI.2.4.041009","journal-title":"J Med Imaging (Bellingham)"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05302-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-025-05302-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05302-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T08:58:21Z","timestamp":1777021101000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-025-05302-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":84,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["5302"],"URL":"https:\/\/doi.org\/10.1007\/s00261-025-05302-2","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}